Exposure-response relationship for bedaquiline, delamanid, and their metabolites

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Investigating the treatment shorting potential of sutezolid-containing regimens in a murine model with confirmed drug exposures

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Operational Challenges with Centralising PK Bioanalysis in a Multicentre Multinational Randomised Controlled Trial

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Optimized loading period strategies for bedaquiline at the restart of drug-resistant tuberculosis treatment

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Pentamidine shows promising activity against M. tuberculosis and M. avium complex but not M. abscessus

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Pharmacokinetics of linezolid in Indian patients with multidrug-resistant tuberculosis

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Pharmacokinetics of Rifampicin in Plasma, Cerebrospinal Fluid, and Brain Extracellular Fluid in South African Children

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

PLASMA BEDAQUILINE LEVELS IN INDIAN MDR-TB PATIENTS

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Population pharmacokinetics of cycloserine, administered as terizidone, in South African children treated for rifampicin-resistant tuberculosis.

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Population Pharmacokinetic Modeling of Pretomanid Dispersible-Tablet Formulation in Healthy Volunteers

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Pravastatin pharmacokinetics when administered simultaneously with first-line tuberculosis treatment

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Rifampin Urine Colorimetry for Evaluation of Tuberculosis Pharmacokinetics

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

Simulation by oral dosing of rifapentine-rifabutin exposures for long-acting formulations in a mouse model of tuberculosis preventive therapy

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021

SARS-CoV-2 antibody seroprevalence in previously undiagnosed persons in Tbilisi, Georgia: Results of three repeated serosurveys

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Rate of HCV reinfection among people living with HCV following successful DAA therapy in Tbilisi, Georgia

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

COVID-19 Challenges and Scale-up in Access to Community-based HCV Treatment for HIV/HCV Co-infected PWIDs in Ukraine

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Dynamics and peculiarities of AIDS mortality in Minsk, Belarus

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

“Evaluate potential impact of COVID-19 pandemic on HIV testing and care national program in the republic of Georgia”

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Effect of remdesivir on mortality in patients with COVID-19: A retrospective cohort study

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Integrating viral hepatitis and PrEP services through KP-led clinics in Vietnam: An opportunity to achieve dual elimination of HIV and viral hepatitis by 2030

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Prevalence of undiagnosed HBV infection in patients with COVID-19

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Obstetric complications in HIV-positive pregnant women, depending on the level of HIV RNA and CD4 count

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Post-discharge mortality among hospitalized HIV positive persons

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Outcomes of HIV pre-exposure prophylaxis (PrEP) program in Georgia for the reporting period from October 2017 to June 2021

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021